Table 4.
Age range | Total number of choice outcomes | Most preferred procedure | Second most preferred procedure | Third most preferred procedure | Fourth most preferred procedure |
---|---|---|---|---|---|
30–40 years | 423 | Trabeculotomy, ab interno | Xena | iStent (two devices)a | Canaloplasty, ab interno |
41–50 years | 174 | Trabeculotomy, ab interno | Xena | iStent (two devices)a | Traditional trabeculectomy |
51–60 years | 180 | Xena | Traditional trabeculectomy | iStent (two devices)a | Trabeculotomy, ab interno |
61–70 years | 66 | Traditional trabeculectomy | Xena | Trabeculotomy, ab interno | iStent (two devices)a |
71 years or older | 14 | Traditional trabeculectomy | Xena | ExPRESSb trabeculectomy | b |
aiStent (Glaukos, San Clemente, CA, USA), Xen gel stent (Allergan, Dublin, Ireland), ExPRESS shunt (Alcon, Inc., Fort Worth, TX USA)
bAll choices in the “71 years or older” group were aggregated in the top three choices